Funds and ETFs Enzychem Lifesciences Corporation

ENZYCHEM LIFESCIENCES CORPORATION is a Korea-based Company mainly engaged in the development and manufacture of medical raw materials. The Company provides D-cycloserine, a synthetic product utilizing chiral technology to treat tuberculosis; antibiotics, such as terizidone, cefbuperazone, cefazedone and others; magnetic resonance imaging (MRI) contrast agents such as gadoterate and gadopentate; others for antithrombotic drugs, antiinflammatory analgesic drugs, and drugs for gastric ulcer and hyperlipidemia. The Company also provides functional health food and finished drug products.